Etienne Puymirat1, Jean Yves Fagon2, Philippe Aegerter3,4,5, Jean Luc Diehl2, Alexandra Monnier2, Caroline Hauw-Berlemont2, Florence Boissier2, Gilles Chatellier6, Bertrand Guidet7, Nicolas Danchin1, Nadia Aissaoui2. 1. Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Européen Georges Pompidou, Cardiologie, and Université Paris 5, Paris, France. 2. AP-HP, Hôpital Européen Georges Pompidou, Intensive Care Unit and Université Paris 5, Paris, France. 3. AP-HP, Hôpital Ambroise Paré, Unité de Recherche Clinique et Département de Santé Publique, Boulogne Billancourt, France. 4. UVSQ, UMR-S 1168, Université Versailles St-Quentin-en-Yvelines, France. 5. INSERM, U1168 VIMA, Villejuif, France. 6. AP-HP, Hôpital Européen Georges Pompidou, Unité de Recherche Clinique and Centre d'Investigation Epidémiologique 4, Paris, France. 7. AP-HP, Hôpital Saint Antoine, Intensive Care Unit and INSERM U444, Paris, France.
Abstract
AIM: To address the paucity of data on the characteristics, outcome and temporal trends in mortality of cardiogenic shock (CS) patients admitted to intensive care units (ICUs) we examined key features, variations in mortality from CS, and predictors of death in ICU patients over the past 15 years. METHODS AND RESULTS: From the 1997-2012 database of the Collège des Utilisateurs de Bases de données en Réanimation (CUB-Réa) that prospectively collects data from ICUs in the greater Paris area, we determined temporal trends in the incidence of CS, patient outcomes [Crude and Simplified Acute Physiology Score (SAPS)-II Standardized Mortality] and predictors of in-ICU mortality. Of the 316 905 ICU admissions, 19 416 (6.1%) exhibited CS, with incidence increasing from 4.1% to 7.7% (P < 0.001). Over time, the age of admitted patients decreased by 2.7 years [95% confidence interval (CI), -2.0 to -3.4] and SAPS-II increased by 5.8% (95% CI 4.8-6.8) from 58.7 ± 25.3 to 64.5 ± 23.3 (P < 0.001). Crude in-ICU mortality declined from 50% to 45% (-5.6%; 95% CI -7.7 to -3.5) as SAPS-II Standardized ICU mortality rates decreased from 56.5% to 44.2% (P < 0.001). A more recent time-period was an independent correlate of decreased mortality in multivariate analyses. The decrease in mortality rate was more marked in patients with decompensated heart failure, cardiac arrest, or acute myocardial infarction. CONCLUSIONS: Patients with CS represent a greater proportion of patients admitted to ICUs over the past 15 years, having become younger but more critically ill. Although their mortality has decreased, suggesting improved overall patient management, it remains particularly high, warranting further research specifically focused on this population.
AIM: To address the paucity of data on the characteristics, outcome and temporal trends in mortality of cardiogenic shock (CS) patients admitted to intensive care units (ICUs) we examined key features, variations in mortality from CS, and predictors of death in ICUpatients over the past 15 years. METHODS AND RESULTS: From the 1997-2012 database of the Collège des Utilisateurs de Bases de données en Réanimation (CUB-Réa) that prospectively collects data from ICUs in the greater Paris area, we determined temporal trends in the incidence of CS, patient outcomes [Crude and Simplified Acute Physiology Score (SAPS)-II Standardized Mortality] and predictors of in-ICU mortality. Of the 316 905 ICU admissions, 19 416 (6.1%) exhibited CS, with incidence increasing from 4.1% to 7.7% (P < 0.001). Over time, the age of admitted patients decreased by 2.7 years [95% confidence interval (CI), -2.0 to -3.4] and SAPS-II increased by 5.8% (95% CI 4.8-6.8) from 58.7 ± 25.3 to 64.5 ± 23.3 (P < 0.001). Crude in-ICU mortality declined from 50% to 45% (-5.6%; 95% CI -7.7 to -3.5) as SAPS-II Standardized ICU mortality rates decreased from 56.5% to 44.2% (P < 0.001). A more recent time-period was an independent correlate of decreased mortality in multivariate analyses. The decrease in mortality rate was more marked in patients with decompensated heart failure, cardiac arrest, or acute myocardial infarction. CONCLUSIONS:Patients with CS represent a greater proportion of patients admitted to ICUs over the past 15 years, having become younger but more critically ill. Although their mortality has decreased, suggesting improved overall patient management, it remains particularly high, warranting further research specifically focused on this population.
Authors: Cosme García-García; Teresa Oliveras; Nabil El Ouaddi; Ferran Rueda; Jordi Serra; Carlos Labata; Marc Ferrer; German Cediel; Santiago Montero; Maria Jose Martínez; Helena Resta; Oriol de Diego; Joan Vila; Irene R Dégano; Roberto Elosua; Josep Lupón; Antoni Bayes-Genis Journal: J Clin Med Date: 2020-07-27 Impact factor: 4.241
Authors: Toni Jäntti; Tuukka Tarvasmäki; Veli-Pekka Harjola; Kari Pulkki; Heidi Turkia; Tuija Sabell; Heli Tolppanen; Raija Jurkko; Mari Hongisto; Anu Kataja; Alessandro Sionis; Jose Silva-Cardoso; Marek Banaszewski; Salvatore DiSomma; Alexandre Mebazaa; Mikko Haapio; Johan Lassus Journal: Ann Intensive Care Date: 2021-02-05 Impact factor: 6.925
Authors: Jakob Josiassen; Ole Kristian Lerche Helgestad; Jacob Eifer Møller; Jesper Kjaergaard; Henrik Frederiksen Hoejgaard; Henrik Schmidt; Lisette Okkels Jensen; Lene Holmvang; Hanne Berg Ravn; Christian Hassager Journal: PLoS One Date: 2020-12-23 Impact factor: 3.240